Ortin Global Q2 Results
- BSE: 539287
- NSE: ORTINGLOBE
- ISIN: INE749B01020
- Sector: Biotechnology & Drugs
BSE
14.97
0.71 (4.98%)
0.71 (4.98%)Volume5.58 K
Updated: Fri 13 Feb, 2026 | 10:46:02
NSE
15.610.74 (4.98%)
0.74 (4.98%)Volume15.74 K
Updated: Fri 13 Feb, 2026 | 13:02:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹0.01 Cr.(-74.45%)
- Operating Profit₹-0.50 Cr.(10.39%)
- Profit After Tax₹-0.50 Cr.(6.37%)
- Operating Margin-3582.14%(332.10%)
Note: Comparison is on YoY basis
Quarterly - Ortin Global Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.52 | 0.24 | 111.79% | 0.51 | 1.26% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.00 | -97.92% |
| Operating Income | -0.50 | -0.20 | 146.32% | -0.45 | 10.39% |
| Net Income | -0.50 | -0.18 | 186.49% | -0.47 | 6.37% |
| Other Operating Expenses Total | 0.48 | 0.16 | 196.34% | 0.40 | 18.94% |
| Net Income Before Taxes | -0.50 | -0.16 | 208.53% | -0.47 | 6.12% |
| Total Revenue | 0.01 | 0.04 | -64.82% | 0.05 | -74.45% |
| Selling/ General/ Admin Expenses Total | 0.04 | 0.04 | 4.79% | 0.03 | 7.20% |
| Diluted Normalized EPS | -0.62 | -0.22 | 181.82% | -0.58 | 6.90% |